Recruitment unclearEUCTR 2011-006099-38
Effects of an antiandrogenic oral contraceptive on eating behaviour in women with bulimia – A randomized double blinded, placebo controlled study.
This historical record does not confirm current site availability.
Historical research recordSwedenEating disorders
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Sweden
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This is historical registry information. What is the current study status and protocol?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Recruitment unclear
- Enrollment listed in the registry
- 100
- Sponsor
- Karolinska University Hospital
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Sweden
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2011-006099-38
- Official title
Show the full official title
Effects of an antiandrogenic oral contraceptive on eating behaviour in women with bulimia – A randomized double blinded, placebo controlled study.
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Sweden
Registry details
Historical country statuses
- Sweden — Ongoing
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Karolinska University Hospital, a hospital or academic medical center.
Want to explore more studies?
Explore studiesRelated studies
Can treatment with vitamin D lower the incidence of osteoporosis in anorexia?
Lisdexamphetamine treatment of Eating disorders with and without probable simultaneous Attention Deficit Hyperactivity Disorder (ADHD). A randomized , open, fase II-study with cross-over design.